Infection Control Market Size(US$)

CAGR 2025-2031
3.7%
Market Size,2031
USD 24,020
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Infection Control market size was US$ 18690 million in 2024 and is forecast to a readjusted size of US$ 24020 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031.
The North America Infection Control market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key players of Infection Control include STERIS, Getinge, Ecolab, 3M, Advanced Sterilization Products, Cantel Medical, Sotera Health, MMM Group, Matachana, Belimed AG, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of revenue, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Infection Control market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Infection Control market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Sterilization Products and Services in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Life Sciences Industry in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Infection Control value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYResearch's Strengths
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Disinfection Products
1.2.3 Sterilization Products and Services
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals & Clinics
1.3.3 Life Sciences Industry
1.3.4 Medical Device Companies
1.3.5 Pharmaceutical Companies
1.3.6 Food Industry
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infection Control Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Infection Control Revenue Market Share by Region (2020-2025)
2.4 Global Infection Control Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Infection Control Market Size and Prospective (2020-2031)
2.5.2 Europe Infection Control Market Size and Prospective (2020-2031)
2.5.3 China Infection Control Market Size and Prospective (2020-2031)
2.5.4 Japan Infection Control Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Infection Control Market Size and Prospective (2020-2031)
2.5.6 India Infection Control Market Size and Prospective (2020-2031)
2.5.7 Central & South America Infection Control Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Infection Control Historic Market Size by Type (2020-2025)
3.2 Global Infection Control Forecasted Market Size by Type (2026-2031)
3.3 Different Types Infection Control Representative Players
4 Breakdown Data by Application
4.1 Global Infection Control Historic Market Size by Application (2020-2025)
4.2 Global Infection Control Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Infection Control Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Infection Control Players by Revenue (2020-2025)
5.1.2 Global Infection Control Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Infection Control Revenue
5.4 Global Infection Control Market Concentration Analysis
5.4.1 Global Infection Control Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Infection Control Revenue in 2024
5.5 Global Key Players of Infection Control Head office and Area Served
5.6 Global Key Players of Infection Control, Product and Application
5.7 Global Key Players of Infection Control, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Infection Control Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Infection Control Market Size by Type (2020-2025)
6.1.2.2 North America Infection Control Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Infection Control Market Size by Application (2020-2025)
6.1.3.2 North America Infection Control Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Infection Control Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Infection Control Market Size by Type (2020-2025)
6.2.2.2 Europe Infection Control Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Infection Control Market Size by Application (2020-2025)
6.2.3.2 Europe Infection Control Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Infection Control Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Infection Control Market Size by Type (2020-2025)
6.3.2.2 China Infection Control Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Infection Control Market Size by Application (2020-2025)
6.3.3.2 China Infection Control Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Infection Control Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Infection Control Market Size by Type (2020-2025)
6.4.2.2 Japan Infection Control Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Infection Control Market Size by Application (2020-2025)
6.4.3.2 Japan Infection Control Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Infection Control Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Infection Control Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Infection Control Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Infection Control Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Infection Control Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Infection Control Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Infection Control Market Size by Type (2020-2025)
6.6.2.2 India Infection Control Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Infection Control Market Size by Application (2020-2025)
6.6.3.2 India Infection Control Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 STERIS
7.1.1 STERIS Company Details
7.1.2 STERIS Business Overview
7.1.3 STERIS Infection Control Introduction
7.1.4 STERIS Revenue in Infection Control Business (2020-2025)
7.1.5 STERIS Recent Development
7.2 Getinge
7.2.1 Getinge Company Details
7.2.2 Getinge Business Overview
7.2.3 Getinge Infection Control Introduction
7.2.4 Getinge Revenue in Infection Control Business (2020-2025)
7.2.5 Getinge Recent Development
7.3 Ecolab
7.3.1 Ecolab Company Details
7.3.2 Ecolab Business Overview
7.3.3 Ecolab Infection Control Introduction
7.3.4 Ecolab Revenue in Infection Control Business (2020-2025)
7.3.5 Ecolab Recent Development
7.4 3M
7.4.1 3M Company Details
7.4.2 3M Business Overview
7.4.3 3M Infection Control Introduction
7.4.4 3M Revenue in Infection Control Business (2020-2025)
7.4.5 3M Recent Development
7.5 Advanced Sterilization Products
7.5.1 Advanced Sterilization Products Company Details
7.5.2 Advanced Sterilization Products Business Overview
7.5.3 Advanced Sterilization Products Infection Control Introduction
7.5.4 Advanced Sterilization Products Revenue in Infection Control Business (2020-2025)
7.5.5 Advanced Sterilization Products Recent Development
7.6 Cantel Medical
7.6.1 Cantel Medical Company Details
7.6.2 Cantel Medical Business Overview
7.6.3 Cantel Medical Infection Control Introduction
7.6.4 Cantel Medical Revenue in Infection Control Business (2020-2025)
7.6.5 Cantel Medical Recent Development
7.7 Sotera Health
7.7.1 Sotera Health Company Details
7.7.2 Sotera Health Business Overview
7.7.3 Sotera Health Infection Control Introduction
7.7.4 Sotera Health Revenue in Infection Control Business (2020-2025)
7.7.5 Sotera Health Recent Development
7.8 MMM Group
7.8.1 MMM Group Company Details
7.8.2 MMM Group Business Overview
7.8.3 MMM Group Infection Control Introduction
7.8.4 MMM Group Revenue in Infection Control Business (2020-2025)
7.8.5 MMM Group Recent Development
7.9 Matachana
7.9.1 Matachana Company Details
7.9.2 Matachana Business Overview
7.9.3 Matachana Infection Control Introduction
7.9.4 Matachana Revenue in Infection Control Business (2020-2025)
7.9.5 Matachana Recent Development
7.10 Belimed AG
7.10.1 Belimed AG Company Details
7.10.2 Belimed AG Business Overview
7.10.3 Belimed AG Infection Control Introduction
7.10.4 Belimed AG Revenue in Infection Control Business (2020-2025)
7.10.5 Belimed AG Recent Development
7.11 Halyard Health
7.11.1 Halyard Health Company Details
7.11.2 Halyard Health Business Overview
7.11.3 Halyard Health Infection Control Introduction
7.11.4 Halyard Health Revenue in Infection Control Business (2020-2025)
7.11.5 Halyard Health Recent Development
7.12 Metrex Research
7.12.1 Metrex Research Company Details
7.12.2 Metrex Research Business Overview
7.12.3 Metrex Research Infection Control Introduction
7.12.4 Metrex Research Revenue in Infection Control Business (2020-2025)
7.12.5 Metrex Research Recent Development
7.13 Reckitt Benckiser
7.13.1 Reckitt Benckiser Company Details
7.13.2 Reckitt Benckiser Business Overview
7.13.3 Reckitt Benckiser Infection Control Introduction
7.13.4 Reckitt Benckiser Revenue in Infection Control Business (2020-2025)
7.13.5 Reckitt Benckiser Recent Development
7.14 Pal International
7.14.1 Pal International Company Details
7.14.2 Pal International Business Overview
7.14.3 Pal International Infection Control Introduction
7.14.4 Pal International Revenue in Infection Control Business (2020-2025)
7.14.5 Pal International Recent Development
8 Infection Control Market Dynamics
8.1 Infection Control Industry Trends
8.2 Infection Control Market Drivers
8.3 Infection Control Market Challenges
8.4 Infection Control Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
List of Figures
Related Reports
The global Infection Control market was valued at US$ 16880 million in 2023 and is anticipated to reach US$ 22490 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
Published Date: 2024-01-16
Pages: 89
USD 2900.00
(Single User License)
The global market for Infection Control was estimated to be worth US$ 16880 million in 2023 and is forecast to a readjusted size of US$ 22490 million by 2030 with a CAGR of 3.7% during the forecast period 2024-2030
Published Date: 2024-01-24
Pages: 108
USD 3950.00
(Single User License)
Market Analysis and Insights: Global Infection Control Market
Published Date: 2024-04-12
Pages: 107
USD 4900.00
(Single User License)
The global market for Infection Control was valued at US$ 18690 million in the year 2024 and is projected to reach a revised size of US$ 24020 million by 2031, growing at a CAGR of 3.7% during the forecast period.
Published Date: 2025-02-27
Pages: 84
USD 2900.00
(Single User License)
The global market for Infection Control was estimated to be worth US$ 18690 million in 2024 and is forecast to a readjusted size of US$ 24020 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 117
USD 3950.00
(Single User License)
The global Infection Control market was valued at US$ 19310 million in 2025 and is anticipated to reach US$ 24820 million by 2032, at a CAGR of 3.7% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 114
USD 2900.00
(Single User License)
The global market for Infection Control was estimated to be worth US$ 19310 million in 2025 and is projected to reach US$ 24820 million, growing at a CAGR of 3.7% from 2026 to 2032.
Published Date: 2026-07-15
Pages: 119
USD 3950.00
(Single User License)
The global Infection Control market was valued at US$ 16880 million in 2023 and is anticipated to reach US$ 22490 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 89
The global market for Infection Control was estimated to be worth US$ 16880 million in 2023 and is forecast to a readjusted size of US$ 22490 million by 2030 with a CAGR of 3.7% during the forecast period 2024-2030
Published: 2024-01-24
Pages: 108
Market Analysis and Insights: Global Infection Control Market
Published: 2024-04-12
Pages: 107
The global market for Infection Control was valued at US$ 18690 million in the year 2024 and is projected to reach a revised size of US$ 24020 million by 2031, growing at a CAGR of 3.7% during the forecast period.
Published: 2025-02-27
Pages: 84
The global market for Infection Control was estimated to be worth US$ 18690 million in 2024 and is forecast to a readjusted size of US$ 24020 million by 2031 with a CAGR of 3.7% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 117
The global Infection Control market was valued at US$ 19310 million in 2025 and is anticipated to reach US$ 24820 million by 2032, at a CAGR of 3.7% from 2026 to 2032.
Published: 2026-04-27
Pages: 114
The global market for Infection Control was estimated to be worth US$ 19310 million in 2025 and is projected to reach US$ 24820 million, growing at a CAGR of 3.7% from 2026 to 2032.
Published: 2026-07-15
Pages: 119
REPORT COVERAGE
Market Segmentation
QYResearch's Strengths
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research